15942-08-2,
trans-4-(6,8-dibromo-1,2-dihydroquinazolin-3(4H)-yl)cyclohexanol hydrochloride,
Ambroxol Cyclic Impurity Hydrochloride,
Cyclohexanol, 4-(6,8-dibromo-1,4-dihydro-3(2H)-quinazolinyl)-, hydrochloride (1:1), trans-,
trans-4-(6,8-Dibromo-1,4-dihydroquinazolin-3(2H)-yl)cyclohexanol Hydrochloride,
Ambroxol Hydrochloride Impurity B,
4-(6,8-dibromo-2,4-dihydro-1H-quinazolin-3-yl)cyclohexan-1-ol;hydrochloride,
metabolites of Bisolvon,
C14H18Br2N2O.HCl,
DTXSID00680609,
MFCD26967902,
AKOS025396549,
ACN-026568,
EX-7791,
FT-0697766,
Z5670,
trans-4-(6,8-Dibromo-1,4-dihydroquinazolin-3(2H)-yl)cyclohexanol HCl,
(1r,4r)-4-(6,8-dibromo-1,2-dihydroquinazolin-3(4H)-yl)cyclohexanol hydrochloride,
(1r,4r)-4-(6,8-dibromo-1,2-dihydroquinazolin-3(4H)-yl)cyclohexanol hydrochloride, rel-,
4-(6,8-Dibromo-1,4-dihydroquinazolin-3(2H)-yl)cyclohexan-1-ol--hydrogen chloride (1/1),
4-(6,8-dibromo-2,4-dihydro-1h-quinazolin-3-yl)cyclohexan-1-ol,hydrochloride,
Ambroxol EP Impurity B,
ICLHRFYBPXBCPE-UHFFFAOYSA-N,
CS-O-07153,